GE HealthCare to Buy Sofie Biosciences for $945M
GE HealthCare has agreed to acquire Sofie Biosciences for $945 million in cash. The deal strengthens its radiopharmaceutical business and cancer detection capabilities.
Xurve View
Insights:
Xurve View
GE HealthCare Technologies agreed on Monday afternoon to acquire Sofie Biosciences for $945M in cash, expanding its radiopharmaceuticals footprint. The transaction strengthens the medical device maker's manufacturing and distribution network for PET imaging drugs. The deal arrives amid rising M&A activity in the oncology sector as healthcare firms race to secure radioactive drug assets.
